Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus reuteri (Reuterin) as a therapeutic agent in infantile colic: prospective study
2004-004124-12Phase 4Active
- Sponsor
- Azienda Ospedaliera O.I.R.M. - S. Anna
- Start
- Jul 2007
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4 trial of lactobacillus reuteri in infant colic, sponsored by Azienda Ospedaliera O.I.R.M. - S. Anna. Started Jul 2007; status: active.
02
Drugs
lactobacillus reuteri
03
Conditions
infant colic
Beyond the preview
Go deeper on 2004-004124-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004124-12.